TY -
GEN
AU - Sonpavde, Guru
AU - Bhor, Menaka
AU - Hennessy, Daniel
AU - Bhowmik, Debajyoti
AU - Shen, Liji
AU - Schnadig, Ian D.
TI -
Impact of number of lines of therapy following docetaxel (D) in metastatic castration-resistant prostate cancer (mCRPC).
PB - American Society of Clinical Oncology (ASCO)
SN - 0732-183X
SN - 1527-7755
KW - Cancer Research
KW - Oncology
PY - 2014
ER -